Baystreet Staff - Tuesday, September 27, 2011 Lorus Therapeutics Inc. 11:45 AM EST - Lorus Therapeutics Inc. : announced the allowance of an Australian patent for its lead small molecule anticancer drug LOR-253. Lorus Therapeutics Inc. shares T.LOR are trading even at $0.30.